Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1007/s10557-020-07066-x

http://scihub22266oqcxt.onion/10.1007/s10557-020-07066-x
suck pdf from google scholar
32870433!7459262!32870433
unlimited free pdf from europmc32870433    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32870433      Cardiovasc+Drugs+Ther 2021 ; 35 (2): 195-203
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19 #MMPMID32870433
  • Aliter KF; Al-Horani RA
  • Cardiovasc Drugs Ther 2021[Apr]; 35 (2): 195-203 PMID32870433show ga
  • Thrombin is a trypsin-like serine protease with multiple physiological functions. Its role in coagulation and thrombosis is well-established. Nevertheless, thrombin also plays a major role in inflammation by activating protease-activated receptors. In addition, thrombin is also involved in angiogenesis, fibrosis, and viral infections. Considering the pathogenesis of COVID-19 pandemic, thrombin inhibitors may exert multiple potential therapeutic benefits including antithrombotic, anti-inflammatory, and antiviral activities. In this review, we describe the clinical features of COVID-19, the thrombin's roles in various pathologies, and the potential of argatroban in COVID-19 patients. Argatroban is a synthetic, small molecule, direct, competitive, and selective inhibitor of thrombin. It is approved to parenterally prevent and/or treat heparin-induced thrombocytopenia in addition to other thrombotic conditions. Argatroban also possesses anti-inflammatory and antiviral activities and has a well-established pharmacokinetics profile. It also appears to lack a significant risk of drug-drug interactions with therapeutics currently being evaluated for COVID-19. Thus, argatroban presents a substantial promise in treating severe cases of COVID-19; however, this promise is yet to be established in randomized, controlled clinical trials.
  • |*COVID-19 Drug Treatment[MESH]
  • |*COVID-19/blood/immunology[MESH]
  • |Antithrombins/pharmacology[MESH]
  • |Arginine/*analogs & derivatives/pharmacology[MESH]
  • |Blood Coagulation/drug effects[MESH]
  • |Drug Development[MESH]
  • |Humans[MESH]
  • |Inflammation/drug therapy[MESH]
  • |Pipecolic Acids/*pharmacology[MESH]
  • |SARS-CoV-2/*drug effects[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box